Metaxalone is a white, odourless crystalline powder used to relax muscles and relieve pain that could have occurred due to strain, sprain, and other musculoskeletal conditions. It has sedative and skeletal muscle relaxant effect on the body and helps relieve pain. The compound is freely soluble in chloroform; however insoluble in ether or water. Market Analysis and Insights: Global Metaxalone Market The global Metaxalone market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Metaxalone Scope and Market Size The global Metaxalone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metaxalone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type Bone Pain Muscle Pain Joint Pain Others Segment by Application Hospitals Clinics Others The Metaxalone market is analysed and market size information is provided by regions (countries). Segment by Application, the Metaxalone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Biosynth Chunghwa Chemical Synthesis and Biotech Sigma-Aldrich CDI Technology Angelini Pfizer Aurum Pharmatech Finetech Industry Biocore Oxchem Corporation
1 Metaxalone Market Overview 1.1 Metaxalone Product Scope 1.2 Metaxalone Segment by Type 1.2.1 Global Metaxalone Sales by Type (2016 & 2021 & 2027) 1.2.2 Bone Pain 1.2.3 Muscle Pain 1.2.4 Joint Pain 1.2.5 Others 1.3 Metaxalone Segment by Application 1.3.1 Global Metaxalone Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2
